Evexia Lifecare [EVEXIA] vs Gujarat Ambuja [GAEL] Detailed Stock Comparison
Evexia Lifecare
BSE
Loading...
Gujarat Ambuja
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Evexia Lifecare wins in 2 metrics, Gujarat Ambuja wins in 16 metrics, with 0 ties. Gujarat Ambuja appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Evexia Lifecare | Gujarat Ambuja | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 201.00 | 20.58 | Gujarat Ambuja |
| Price-to-Book Ratio | 0.41 | 1.62 | Evexia Lifecare |
| Debt-to-Equity Ratio | 82.72 | 7.62 | Gujarat Ambuja |
| PEG Ratio | N/A | -1.37 | N/A |
| EV/EBITDA | 113.42 | 11.18 | Gujarat Ambuja |
| Profit Margin (TTM) | 1.19% | 4.94% | Gujarat Ambuja |
| Operating Margin (TTM) | 3.91% | 4.71% | Gujarat Ambuja |
| EBITDA Margin (TTM) | 3.91% | 4.71% | Gujarat Ambuja |
| Return on Equity | 0.20% | 8.30% | Gujarat Ambuja |
| Return on Assets (TTM) | 0.10% | 6.95% | Gujarat Ambuja |
| Free Cash Flow (TTM) | $-342.38M | $441.50M | Gujarat Ambuja |
| Dividend Yield | N/A | 0.58% | N/A |
| 1-Year Return | -52.15% | -24.81% | Gujarat Ambuja |
| Price-to-Sales Ratio (TTM) | 3.39 | 1.02 | Gujarat Ambuja |
| Enterprise Value | $5.74B | $43.47B | Gujarat Ambuja |
| EV/Revenue Ratio | 5.16 | 0.90 | Gujarat Ambuja |
| Gross Profit Margin (TTM) | 8.22% | 24.64% | Gujarat Ambuja |
| Revenue per Share (TTM) | $1 | $105 | Gujarat Ambuja |
| Earnings per Share (Diluted) | $0.01 | $5.19 | Gujarat Ambuja |
| Beta (Stock Volatility) | -0.21 | -0.20 | Evexia Lifecare |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Evexia Lifecare vs Gujarat Ambuja Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Evexia Lifecare | 2.04% | -2.44% | -10.31% | -17.36% | -21.26% | -43.50% |
| Gujarat Ambuja | -0.03% | -0.31% | -1.73% | -5.20% | -8.88% | -15.85% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Evexia Lifecare | -52.15% | 10.50% | -98.58% | -98.58% | -98.58% | -98.58% |
| Gujarat Ambuja | -24.81% | -20.40% | 78.50% | 638.49% | 492.87% | 1,032.30% |
News Based Sentiment: Evexia Lifecare vs Gujarat Ambuja
Evexia Lifecare
News based Sentiment: MIXED
Evexia Lifecare reported strong financial results in Q2 2025, demonstrating significant revenue and profit growth. However, this positive news was offset by a valuation downgrade and concerns about the company's high P/E ratio, creating a mixed investment narrative for the month.
Gujarat Ambuja
News based Sentiment: MIXED
The month showcased a blend of positive and negative developments for Gujarat Ambuja Exports. While revenue increased in the latest quarter, profitability declined, and full-year results showed decreased sales and profits. This creates a mixed investment picture, warranting caution and close monitoring.
Performance & Financial Health Analysis: Evexia Lifecare vs Gujarat Ambuja
| Metric | EVEXIA | GAEL |
|---|---|---|
| Market Information | ||
| Market Cap | ₹3.77B | ₹49.06B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 1,939,017 | 225,902 |
| 90 Day Avg. Volume | 2,474,343 | 338,138 |
| Last Close | ₹2.00 | ₹105.53 |
| 52 Week Range | ₹1.86 - ₹3.73 | ₹98.72 - ₹146.95 |
| % from 52W High | -46.38% | -28.19% |
| All-Time High | ₹165.00 (Mar 15, 2021) | ₹210.60 (Jan 29, 2024) |
| % from All-Time High | -98.79% | -49.89% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.04% | 0.18% |
| Quarterly Earnings Growth | 1.63% | -0.15% |
| Financial Health | ||
| Profit Margin (TTM) | 0.01% | 0.05% |
| Operating Margin (TTM) | 0.04% | 0.05% |
| Return on Equity (TTM) | 0.00% | 0.08% |
| Debt to Equity (MRQ) | 82.72 | 7.62 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹4.94 | ₹65.88 |
| Cash per Share (MRQ) | ₹0.06 | ₹16.85 |
| Operating Cash Flow (TTM) | ₹-29,906,000 | ₹3.14B |
| Levered Free Cash Flow (TTM) | ₹9.30M | ₹2.49B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.58% |
| Last 12-Month Dividend | N/A | ₹0.60 |
Valuation & Enterprise Metrics Analysis: Evexia Lifecare vs Gujarat Ambuja
| Metric | EVEXIA | GAEL |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 201.00 | 20.58 |
| Forward P/E | N/A | 11.48 |
| PEG Ratio | N/A | -1.37 |
| Price to Sales (TTM) | 3.39 | 1.02 |
| Price to Book (MRQ) | 0.41 | 1.62 |
| Market Capitalization | ||
| Market Capitalization | ₹3.77B | ₹49.06B |
| Enterprise Value | ₹5.74B | ₹43.47B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 5.16 | 0.90 |
| Enterprise to EBITDA | 113.42 | 11.18 |
| Risk & Other Metrics | ||
| Beta | -0.21 | -0.20 |
| Book Value per Share (MRQ) | ₹4.94 | ₹65.88 |
Financial Statements Comparison: Evexia Lifecare vs Gujarat Ambuja
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | EVEXIA | GAEL |
|---|---|---|
| Revenue/Sales | ₹220.93M | ₹12.91B |
| Cost of Goods Sold | ₹202.76M | ₹9.73B |
| Gross Profit | ₹18.17M | ₹3.18B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹8.65M | ₹607.80M |
| EBITDA | ₹10.78M | ₹1.27B |
| Pre-Tax Income | ₹8.58M | ₹856.70M |
| Income Tax | ₹2.23M | ₹206.50M |
| Net Income (Profit) | ₹6.35M | ₹650.20M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | EVEXIA | GAEL |
|---|---|---|
| Cash & Equivalents | ₹41.44M | ₹12.20M |
| Total Current Assets | ₹1.18B | ₹19.38B |
| Total Current Liabilities | ₹793.14M | ₹4.58B |
| Long-Term Debt | ₹3.75B | ₹98.20M |
| Total Shareholders Equity | ₹4.66B | ₹30.02B |
| Retained Earnings | N/A | ₹27.75B |
| Property, Plant & Equipment | ₹223.76M | ₹554.90M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | EVEXIA | GAEL |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | EVEXIA | GAEL |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 1,939,017 | 225,902 |
| Average Daily Volume (90 Day) | 2,474,343 | 338,138 |
| Shares Outstanding | 1.88B | 458.67M |
| Float Shares | 528.29M | 137.05M |
| % Held by Insiders | 0.50% | 0.70% |
| % Held by Institutions | 0.05% | 0.01% |
Dividend Analysis & Yield Comparison: Evexia Lifecare vs Gujarat Ambuja
| Metric | EVEXIA | GAEL |
|---|---|---|
| Last 12-Month Dividend | N/A | ₹0.60 |
| Last 12-Month Dividend Yield | N/A | 0.58% |
| 3-Year Avg Annual Dividend | N/A | ₹0.26 |
| 3-Year Avg Dividend Yield | N/A | 0.20% |
| 3-Year Total Dividends | N/A | ₹0.77 |
| Ex-Dividend Date | N/A | Aug 22, 2025 |